Irinotecan Koanaa 20mg/ml Concentrate for Solution for Infusion (25ml vial) Малта - английски - Medicines Authority

irinotecan koanaa 20mg/ml concentrate for solution for infusion (25ml vial)

koanaa healthcare limited - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 milligram(s)/millilitre - antineoplastic agents

Irinotecan Mylan 20 mg/ml concentrate for solution for infusion Ирландия - английски - HPRA (Health Products Regulatory Authority)

irinotecan mylan 20 mg/ml concentrate for solution for infusion

mcdermott laboratories ltd., t/a gerard laboratories - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; irinotecan

Irinotecan Mylan 20 mg/ml, concentrate for solution for infusion (2ml Vial) Малта - английски - Medicines Authority

irinotecan mylan 20 mg/ml, concentrate for solution for infusion (2ml vial)

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 40/2 mg/ml - antineoplastic agents

Irinotecan Mylan 20mg/ml, concentrate for solution for infusion (5ml vial) Малта - английски - Medicines Authority

irinotecan mylan 20mg/ml, concentrate for solution for infusion (5ml vial)

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 100 mg/5ml - antineoplastic agents

Irinotecan Mylan 20mg/ml, concentrate for solution for infusion (15ml vial) Малта - английски - Medicines Authority

irinotecan mylan 20mg/ml, concentrate for solution for infusion (15ml vial)

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 300/15 mg/ml - antineoplastic agents

Irinotecan Mylan 20mg/ml Concentrate for Solution for Infusion (25ml vial) Малта - английски - Medicines Authority

irinotecan mylan 20mg/ml concentrate for solution for infusion (25ml vial)

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

ASPEN OXALIPLATIN 50 mg/10 ml INJECTION Южна Африка - английски - South African Health Products Regulatory Authority (SAHPRA)

aspen oxaliplatin 50 mg/10 ml injection

pharmacare limited û woodmead - injection - see ingredients - each vial contains oxaliplatin 50,0 mg

ASPEN OXALIPLATIN 100 mg/20 ml INJECTION Южна Африка - английски - South African Health Products Regulatory Authority (SAHPRA)

aspen oxaliplatin 100 mg/20 ml injection

pharmacare limited û woodmead - injection - see ingredients - each vial contains oxaliplatin 100,0 mg

ASPEN OXALIPLATIN 200 mg/40 ml INJECTION Южна Африка - английски - South African Health Products Regulatory Authority (SAHPRA)

aspen oxaliplatin 200 mg/40 ml injection

pharmacare limited û woodmead - injection - see ingredients - each vial contains oxaliplatin 200,0 mg

Pacliccord Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pacliccord

pharmacy retailing (nz) ltd t/a healthcare logistics - paclitaxel 6 mg/ml - concentrate for infusion - 6 mg/ml - active: paclitaxel 6 mg/ml excipient: ethanol polyoxyl 35 castor oil - paclitaxel is indicated for: primary treatment of ovarian cancer in combination with other chemotherapeutic agents. treatment of metastatic carcinoma of the ovary after failure of standard therapy.